Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Facilitating compliance with antipsychotic medication

S R Marder1

  • 1West Los Angeles Veterans Affairs Medical Center and the University of California at Los Angeles School of Medicine, 90073, USA.

The Journal of Clinical Psychiatry
|April 16, 1998
PubMed
Summary

Medication noncompliance in schizophrenia leads to rehospitalization. Newer antipsychotics, like clozapine, improve symptoms and cognition, fostering "involved compliance" and potentially reducing societal costs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Childhood adversity and cognitive function in schizophrenia spectrum disorders and healthy controls: evidence for an association between neglect and social cognition.

Psychological medicine·2017
Same author

Evidence for genetic heterogeneity between clinical subtypes of bipolar disorder.

Translational psychiatry·2017
Same author

Repurposing Drugs for Cognition in Schizophrenia.

Clinical pharmacology and therapeutics·2016
Same author

Efficient light emission from inorganic and organic semiconductor hybrid structures by energy-level tuning.

Nature communications·2015
Same author

Efficacy of lurasidone across five symptom dimensions of schizophrenia: pooled analysis of short-term, placebo-controlled studies.

European psychiatry : the journal of the Association of European Psychiatrists·2014
Same author

Adsorption studies of a phosphonic acid on ITO: film coverage, purity, and induced electronic structure changes.

Physical chemistry chemical physics : PCCP·2014

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Medication noncompliance is prevalent in schizophrenia, contributing to rehospitalization.
  • Traditional risk assessments for noncompliance exist.
  • Previous treatments (D2 antagonists) caused side effects, impacting adherence.

Purpose of the Study:

  • To explore how newer antipsychotics facilitate patient compliance in schizophrenia.
  • To investigate the role of improved cognition and therapeutic alliance in medication adherence.

Main Methods:

  • Review of newer antipsychotic mechanisms and effects.
  • Analysis of clozapine's impact on cognition and adherence.
  • Discussion of therapeutic alliance formation during monitoring.

Main Results:

  • Newer antipsychotics (serotonin-dopamine antagonists) reduce symptoms without extrapyramidal side effects.
  • Clozapine and similar drugs may enhance cognitive functions.
  • Improved cognition and monitoring facilitate "involved compliance".

Conclusions:

  • Newer antipsychotics can improve schizophrenia treatment outcomes by enhancing patient insight and adherence.
  • Facilitating "involved compliance" may decrease the societal burden of schizophrenia.

Related Experiment Videos